Cooper Companies (COO): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Cooper Companies ( COO) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.2%. By the end of trading, Cooper Companies rose $1.22 (1.3%) to $94.49 on average volume. Throughout the day, 605,757 shares of Cooper Companies exchanged hands as compared to its average daily volume of 481,600 shares. The stock ranged in a price between $93.50-$95.18 after having opened the day at $93.81 as compared to the previous trading day's close of $93.27. Other companies within the Health Services industry that increased today were: Bovie Medical Corporation ( BVX), up 19.7%, Graymark Healthcare ( GRMH), up 17.8%, Echo Therapeutics ( ECTE), up 15.8%, and Spherix ( SPEX), up 9%.
  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

The Cooper Companies, Inc. engages in the provision of medical devices for healthcare professionals worldwide. Cooper Companies has a market cap of $4.49 billion and is part of the health care sector. The company has a P/E ratio of 19.7, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 32.3% year to date as of the close of trading on Monday. Currently there are eight analysts that rate Cooper Companies a buy, no analysts rate it a sell, and one rates it a hold.

TheStreet Ratings rates Cooper Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Urologix ( ULGX), down 8.6%, Sunshine Heart ( SSH), down 8.5%, Escalon Medical Corporation ( ESMC), down 7%, and Ironwood Pharmaceuticals ( IRWD), down 6.7%, were all laggards within the health services industry with Intuitive Surgical ( ISRG) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
null

If you liked this article you might like

Teva Nailed With S&P Downgrade

Teva Nailed With S&P Downgrade

7 Investment Themes You Can't Afford to Miss for 2018

7 Investment Themes You Can't Afford to Miss for 2018

Teva Still Has Big Problems It Must Deal With in 2018

Teva Still Has Big Problems It Must Deal With in 2018

Teva Closes Higher as Generic Drugmaker Announces Massive Layoffs, Asset Sales

Teva Closes Higher as Generic Drugmaker Announces Massive Layoffs, Asset Sales

The 60-Year-Old Gold Bug and the 25-Year-Old Bitcoin Fan Are Alike: Market Recon

The 60-Year-Old Gold Bug and the 25-Year-Old Bitcoin Fan Are Alike: Market Recon